Context Therapeutics to Appoint Dr. Karen Chagin, M.D. as Chief Medical Officer May 29, 2025 07:30AM
Galapagos NV (GLPG) and Adaptimmune (ADAP) Enter Collaboration Agreement Over uza-cel May 30, 2024 04:02PM
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential future May 30, 2024 04:01PM
Galapagos and Adaptimmune sign clinical collaboration agreement with an option to exclusively license Adaptimmune’s TCR T-cell therapy candidate, uza-cel, in head & neck cancer and potential fut May 30, 2024 04:01PM
Adaptimmune and Galapagos Sign Clinical Collaboration Agreement with an Option to Exclusively License Adaptimmune's TCR T-cell Therapy Candidate, uza-cel, in Head & Neck Cancer and Potential Future So May 30, 2024 04:01PM


May 16, 2023 07:00AM AlloVir Announces Appointment of Cintia Piccina, PharmD, MBA, as Chief Commercial Officer
Nov 14, 2022 08:00AM ReCode Therapeutics Establishes Scientific Advisory Board
Aug 24, 2022 04:00PM Alnylam Announces Appointment of Elliott Sigal, M.D., Ph.D., to Board of Directors
Jun 15, 2022 07:00AM LAVA Therapeutics Announces Two Appointments to its Board of Directors
Mar 1, 2022 10:05AM Oxford Properties Group and Ensemble/Mosaic Partner to Create 3 Million Square Foot Life Sciences Hub at the Navy Yard in Philadelphia
Oct 26, 2021 06:30AM Tal Zaks Joins Strategic Advisory Board at Deep Genomics
Jan 4, 2021 07:00AM G1 Therapeutics Announces Appointment of William C. Roberts as Vice President, Investor Relations & Corporate Communications
Dec 11, 2020 08:05PM Annual Changes to the Nasdaq Biotechnology Index
Dec 13, 2019 08:10PM Annual Changes to the NASDAQ Biotechnology Index
Nov 7, 2019 04:05PM Cryoport Revenue Grows 81% for Third Quarter 2019
Oct 9, 2019 08:00AM Adaptimmune and Cryoport Announce Agreement to Ensure Safe and Fully Monitored Transport of Adaptimmune’s Cell Therapies
Mar 12, 2018 06:45AM Zynerba Pharmaceuticals Reports Fourth Quarter and Year End 2017 Financial Results and Operational Highlights
Jun 14, 2017 06:00AM BioLife Solutions Executes Supply Agreement with Adaptimmune for CryoStor® Use in SPEAR T-Cell Platform
Mar 1, 2017 08:30AM Adaptimmune Cuts Ribbon on U.S. Headquarters at the Navy Yard in Philadelphia
Oct 9, 2015 08:30AM Adaptimmune Growth Leads to Long-Term Expansion Plans in Philadelphia
May 6, 2015 11:00AM Adaptimmune Therapeutics plc (Nasdaq: ADAP) to Ring The Nasdaq Stock Market Opening Bell